Bengaluru-based health-tech startup Ultrahuman is reportedly in advanced discussions to raise a fresh $120 million funding round, with WestBridge Capital expected to lead the charge. This potential investment comes roughly a year after the company closed its $35 million Series B round, signaling strong investor confidence in the brand’s momentum and future vision.
According to a report by Moneycontrol, private equity funds may also join the round, which could value Ultrahuman between $550 and $600 million—a significant leap reflecting the startup’s rapid growth in the self-quantification and health performance space.
Founded by Mohit Kumar, Ultrahuman has raised more than $60 million to date from a lineup of high-profile backers including Zomato CEO Deepinder Goyal, Nexus Ventures, Blume Ventures, and Alpha Wave. What started as a niche wellness tech play has now grown into a full-fledged performance monitoring ecosystem.
The company’s product suite includes the Ring Air, a smart wearable focused on sleep, recovery, and movement tracking; M1 Live, a continuous glucose monitoring device; and Blood Vision, a diagnostic product for detailed biomarker analysis. Earlier this year, Ultrahuman also debuted Rare, its luxury smart ring collection, further blurring the line between health tech and high-end lifestyle.
On the business front, Ultrahuman reported a strong calendar year 2024, with its operating revenue soaring to $74.5 million (around ₹620 crore). The company also claims to have delivered a healthy 11% profit before tax and 8% EBITDA, showing not just scale but also financial discipline—rare for a hardware-driven tech firm in growth mode.
Ultrahuman’s rise coincides with a growing global interest in personalized health data and preventative care. As wearables become a mainstay in everyday life, the company is positioning itself at the intersection of technology, wellness, and longevity.
